After adjusting for factors such as age, sex and race, as well as health-related issues such as high blood pressure and ...

The study found people who used proton pump inhibitors for more than 4.4 years were 33% more likely to be diagnosed with the ...

Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD: Braintree, Massachusetts Friday, April 25, 2025, 18:00 Hrs [IST] Braintree Laborator ...

“Tegoprazan offers an exciting new treatment option for individuals suffering from GERD, helping to address the substantial unmet need of patients not well-controlled by conventional PPI therapy,” ...

Neurologists have discovered that a common household drug, which has been previously linked to higher risk of stroke, broken ...

Regularly taking this tablet could increase the risk of developing the degenerative disease by as much as a third.

The patient failed to respond to different proton pump inhibitors (PPIs) – omeprazole, pantoprazole and esomeprazole at high ...

Gastroesophageal reflux disease (GERD), also known as gastro oesophageal reflux disease, is more than just the occasional ...

Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in ...